Sputnik V COVID-19 vaccine - statistics & facts

Sputnik V (the V is pronounced as a letter), also known as Gam-COVID-Vac, is a COVID-19 vaccine developed by the Gamaleya Research Institute in Russia. In August 2020, it became the first registered vaccine against the disease worldwide. Scientists in Russia and abroad criticized that the approval took place before the third phase of clinical trials. In February 2021, an article published in the medical journal The Lancet stated that the efficacy of Sputnik V stood at 91.6 percent, which significantly improved the vaccine's reputation. Over 70 countries approved the use of Sputnik V as of November 2021. The vaccine was free in Russia and cost 10 U.S. dollars per dose abroad. In May 2021, Russia registered Sputnik Light, a one-shot COVID-19 vaccine which contained the first component of Sputnik V. According to the Russian Direct Investment Fund, Sputnik Light showed an efficacy of 79.4 percent.

How does Sputnik V work?

According to the manufacturer, Sputnik V is a vector-based vaccine. It consists of two human adenoviral vectors, or genetically modified viruses carrying protein-coding genes from the spike of coronavirus. The first vector, Ad26, is transmitted with the first dose, aimed at boosting immunization. The second vector, Ad5, reaches the body with the second dose 21 days after the first one, in order to strengthen the immune response and to prolong immunity. Other vector-based COVID-19 vaccines include AstraZeneca, or Vaxzevria, from Oxford and Janssen/Johnson & Johnson. The difference in Sputnik V is that it uses two different vectors, according to the aforementioned study in The Lancet.

Which countries use Sputnik V?

Russia started vaccination with Sputnik V among adults in late 2020. Several Latin American countries, such as Argentina, Brazil, Mexico, and Venezuela secured supplies of the vaccine shortly after its approval. In Africa, Sputnik V was administered in Algeria, Egypt, and Tunisia. Among countries in Asia, doses were ordered by Iran and Nepal. Furthermore, Russia supplied Sputnik V to its neighbors, such as Armenia, Belarus, Kazakhstan, and Mongolia. Besides Russia, Sputnik V production takes place in Argentina, Belarus, China, India, South Korea, and several other countries.

Is Sputnik V available in Europe?

Russia applied for the emergency use validation by the World Health Organization in late 2020 and for approval from the European Medical Agency in early 2021. Most European Union members did not approve the use of Sputnik V, waiting for the EMA decision, with the exception of Hungary and Slovakia. Sputnik V accounted for roughly eight percent of total COVID-19 vaccine doses distributed in Hungary as of November 2021. Outside the EU, Bosnia and Herzegovina, North Macedonia, San Marino, and Serbia permitted using the vaccine. In March 2022, WHO postponed Sputnik V's evaluation due to Russia's invasion of Ukraine in February of that year.
This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.
Published by Statista Research Department, Feb 22, 2024

Key insights

Russians vaccinated with Sputnik V (two doses) as of March 31, 2021
3.8m
Number of countries using Sputnik V as of March 2021
18
Number of Sputnik V doses ordered worldwide as of March 2021
765m
Get more insights

Editor’s Picks Current statistics on this topic

Distribution of COVID-19 vaccine doses distributed to the European Economic Area (EEA) as of July 21, 2022, by manufacturer

Prevention

COVID-19 vaccine doses distributed to the EEA in 2022, by manufacturer

Number of people vaccinated and fully vaccinated against COVID-19 per 100 population in Russia from December 15, 2020 to May 26, 2023

Biotechnology

COVID-19 vaccination rate in Russia 2020-2023

Number of confirmed doses of COVID-19 vaccines for Mexico as of June 1, 2022, by vaccine producer (in millions)

Prevention

COVID-19 vaccines confirmed doses in Mexico 2022, by producer

Further recommended statistics

Further reports

Get the best reports to understand your industry

Coronavirus (COVID-19) in the CEE region
Coronavirus (COVID-19) in the CEE region
COVID-19: Steps towards the vaccine
COVID-19: Steps towards the vaccine
Coronavirus (COVID-19): vaccines and vaccination campaign
Coronavirus (COVID-19): vaccines and vaccination campaign
COVID-19 vaccination in Spain
COVID-19 vaccination in Spain
State of Vaccine Confidence in the EU and the UK (2020)
State of Vaccine Confidence in the EU and the UK (2020)

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)
Email
eu.support@statista.com

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
latam@statista.com

Mon - Fri, 9am - 6pm (EST)

Menu